Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10661studies shown

Showing 9,181-9,192 of 10,661

Drug study icon

CompletedNCT00556959

Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

This study is completed in the United States. It focuses on ADHD.

In United States

ADHDDrugFrom 6 Years to 17 Years

Countries: United States
Sponsor: Addrenex Pharmaceuticals, Inc.
Condition: ADHD

Drug study icon

CompletedNCT00406315

Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone

This study is completed in the United States, in Brazil, in Germany, .... It focuses on Schizophrenia.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States, Brazil, Germany, ...
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT00563706

Study Evaluating Vabicaserin in Subjects With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States, Canada
Sponsor: Pfizer
Condition: Schizophrenia

Drug study icon

CompletedNCT03769064

Study for Naltrexone on the Abuse Potential of Methylphenidate

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: Avekshan LLC
Condition: ADHD

Drug study icon

CompletedNCT00982020

Study in Adolescents With Schizophrenia or Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, SchizophreniaDrugFrom 13 Years to 17 Years

Countries: United States, Poland, Russia
Sponsor: Eli Lilly and Company
Condition: Bipolarity, Schizophrenia

Drug study icon

CompletedNCT04221230

Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs Placebo

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Neumora Therapeutics, Inc.
Condition: Depression

Drug study icon

CompletedNCT02658357

Study in Stabilized Schizophrenic Patients Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant

This study is completed in the United States. It focuses on Schizophrenia.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Braeburn Pharmaceuticals
Condition: Schizophrenia

Drug study icon

CompletedNCT02901587

Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder

This study is completed in the United States. It focuses on schizophrenia.

In United States

SchizophreniaDrugFrom 21 Years to 60 Years

Countries: United States
Sponsor: H. Lundbeck A/S
Condition: Schizophrenia

Drug study icon

CompletedNCT01499563

a Novel Antipsychotic ITI-007 in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Schizophrenia

Behavioral study icon

CompletedNCT05603923

A PST-Trained Voice-Enabled Artificial Intelligence Counselor(SPEAC) for Adults With Emotional Distress (Phase 2)

This study is completed in the United States. It is testing PST-Trained Voice-Enabled Artificial Intelligence Counselor for Anxiety.

In United States

Anxiety, DepressionBehavioralOver 18 Years

Countries: United States
Sponsor: University of Illinois at Chicago
Condition: Anxiety, Depression

Behavioral study icon

CompletedNCT03315208

a Transdiagnostic, Emotion-focused Group Intervention for Young Adults With Substance Use Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Addiction, Suicidality, ...BehavioralFrom 18 Years to 26 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Addiction, Suicidality, ...

Drug study icon

Active Not RecruitingNCT06869187

ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolarity in Adults

This study is looking at whether ABX-002 can help people with bipolarity Depression. Participants receive a study treatment and complete follow-up visits and assessments.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Autobahn Therapeutics, Inc.
Condition: Bipolarity, Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.